Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ / shares in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2025	Dec. 31, 2024
Net revenues	$ 803,088	$ 749,510	$ 2,664,261	$ 2,447,391
Cost of sales	530,592	481,331	1,534,675	1,239,527
Gross Profit	272,496	268,179	1,129,586	1,207,864
Operating expenses:
Research and development	180,214	161,005	402,543	400,583
Selling, general and administrative	176,723	196,443	699,697	778,127
Total operating expenses	356,937	357,448	1,102,240	1,178,710
Income (loss) from operations	(84,441)	(89,269)	27,346	29,154
us-gaap_OtherIncomeAndExpensesAbstract
Interest income	2,509	2,923	5,764	10,659
Interest and finance expenses	(7,424)	(8,331)	(22,754)	(25,509)
Gain/(loss) from investment	(25,500)	(142,500)	89,250	(31,000)
Total other income (expense)	(30,415)	(147,908)	72,260	(45,850)
Income (loss) before provision for income taxes	(114,856)	(237,177)	99,606	(16,696)
Provision for income taxes:
Current	0	500	1,500	1,500
Deferred	0	0	0	0
Total provision (benefit) for income taxes	0	500	1,500	1,500
Net income (loss)	$ (114,856)	$ (237,677)	$ 98,106	$ (18,196)
Basic and diluted per common share: (in dollars per share)	$ (0)	$ (0)	$ 0	$ (0)
Weighted average shares of common stock outstanding - basic and diluted (in shares)	67,588,492	67,588,492	67,588,492	67,588,492